[低剂量口服避孕药诺孕酯的临床研究]
[Clinical study of the low dose oral contraceptive novynette].
作者信息
Uchikova E, Milchev N
机构信息
Medical University, Plovdiv.
出版信息
Akush Ginekol (Sofiia). 2003;42(4):15-6.
PMID:14577362
Abstract
The authors review the efficacy, control of the menstrual cycle and the tolerance of the low-dosed oral contraceptive Novynette (20 mkg EE/150 desogestrel) of Gedeon Richter at 25 women, included in the study. The results show: Pearl index = 0.00, a good control over the menstrual cycle, not significant and transitor side effects.
摘要
作者回顾了25名纳入研究的女性使用吉德昂·里奇特公司生产的低剂量口服避孕药诺孕酯（炔雌醇20微克/去氧孕烯150微克）的疗效、月经周期控制情况和耐受性。结果显示：Pearl指数 = 0.00，月经周期控制良好，副作用不显著且为一过性。
Zotero 插件